Koninklijke DSM (RDSMY) Short Interest Ratio & Short Volume → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free RDSMY Stock Alerts $33.85 +1.08 (+3.30%) (As of 11/11/2022) Add Compare Share Share Short InterestStock Analysis Koninklijke DSM Short Interest DataCurrent Short Volume25,000 sharesPrevious Short Volume43,900 sharesChange Vs. Previous Month-43.05%Dollar Volume Sold Short$707,000.00Short Interest Ratio / Days to Cover0.1Last Record DateOctober 15, 2022Outstanding Shares699,144,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume56,500 sharesAverage Trading Volume116,034 sharesToday's Volume Vs. Average49% Short Selling Koninklijke DSM ? Sign up to receive the latest short interest report for Koninklijke DSM and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRDSMY Short Interest Over TimeRDSMY Days to Cover Over TimeRDSMY Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Koninklijke DSM Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202225,000 shares $707,000.00 -43.1%N/A0.1 $28.28 9/30/202243,900 shares $1.25 million +7,216.7%N/A0.1 $28.40 9/15/2022600 shares $17,988.00 No ChangeN/A0 $29.98 8/15/20228,200 shares $311,354.00 -52.9%N/A0.1 $37.97 7/31/202217,400 shares $699,132.00 +31.8%N/A0.2 $40.18 7/15/202213,200 shares $479,160.00 -22.8%N/A0.1 $36.30 Get the Latest News and Ratings for RDSMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter. 6/30/202217,100 shares $614,745.00 -52.0%N/A0.1 $35.95 6/15/202235,600 shares $1.36 million +256.0%N/A0.3 $38.08 5/31/202210,000 shares $424,400.00 -2.9%N/A0 $42.44 5/15/202210,300 shares $380,070.00 -28.5%N/A0.1 $36.90 4/30/202214,400 shares $601,344.00 +37.1%N/A0.1 $41.76 4/15/202210,500 shares $447,888.00 -46.7%N/A0.1 $42.66 3/31/202219,700 shares $883,151.00 +26.3%N/A0.2 $44.83 3/15/202215,600 shares $664,560.00 -51.1%N/A0.1 $42.60 2/28/202231,900 shares $1.48 million +192.7%N/A0.2 $46.43 2/15/202210,900 shares $501,454.50 -76.6%N/A0.1 $46.01 1/31/202246,500 shares $2.18 million +220.7%N/A0.5 $46.97 1/15/202214,500 shares $735,585.00 -27.1%N/A0.3 $50.73 12/31/202119,900 shares $1.13 million -40.1%N/A0.2 $56.61 12/15/202133,200 shares $1.84 million +122.8%N/A0.8 $55.36 11/30/202114,900 shares $804,749.00 -31.0%N/A0.4 $54.01 11/15/202121,600 shares $1.20 million -17.2%N/A0.6 $55.39 10/29/202126,100 shares $1.43 million +29.2%N/A0.6 $54.70 10/15/202120,200 shares $1.07 million -33.8%N/A0.3 $53.10 9/30/202130,500 shares $1.52 million +113.3%N/A0.5 $49.98 9/15/202114,300 shares $786,643.00 -32.9%N/A0.4 $55.01 8/31/202121,300 shares $1.14 million -45.7%N/A0.5 $53.31 8/13/202139,200 shares $2.06 million -4.9%N/A1 $52.47 7/30/202141,200 shares $2.08 million -1.4%N/A1 $50.41 7/15/202141,800 shares $2.03 million -46.5%N/A1.2 $48.48 6/30/202178,100 shares $3.65 million +66.5%N/A1.3 $46.78 6/15/202146,900 shares $2.17 million -77.6%N/A1 $46.18 5/28/2021211,200 shares $9.74 million +36.8%N/A3.6 $46.11 5/14/2021154,400 shares $6.91 million +7.0%N/A2.3 $44.77 4/30/2021144,300 shares $6.59 million +6.3%N/A4.5 $45.68 4/15/2021135,700 shares $6.08 million +3.5%N/A4.3 $44.78 3/31/2021131,100 shares $5.70 million -9.8%N/A2.6 $43.51 3/15/2021145,300 shares $6.18 million +8.0%N/A3 $42.56 2/26/2021134,500 shares $5.69 million +1.0%N/A2.9 $42.27 2/12/2021133,200 shares $5.89 million -16.2%N/A2.1 $44.24Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> RDSMY Short Interest - Frequently Asked Questions What is Koninklijke DSM's current short interest? Short interest is the volume of Koninklijke DSM shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 25,000 shares of RDSMY short. Learn More on Koninklijke DSM's current short interest. Is Koninklijke DSM's short interest increasing or decreasing? Koninklijke DSM saw a drop in short interest in October. As of October 15th, there was short interest totaling 25,000 shares, a drop of 43.1% from the previous total of 43,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Koninklijke DSM's short interest compare to its competitors? Here is how the short interest of companies in the sector of "basic materials" compare to Koninklijke DSM: FMC Co. (7.87%), Olin Co. (1.98%), Basf Se (0.00%), Teck Resources Limited (1.26%), Wheaton Precious Metals Corp. (4.25%), Franco-Nevada Co. (1.58%), Steel Dynamics, Inc. (3.31%), Novozymes A/S (0.00%), Nutrien Ltd. (0.77%), Nippon Steel Co. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), PG&E Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Co. ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks. What does it mean to sell short Koninklijke DSM stock? Short selling RDSMY is an investing strategy that aims to generate trading profit from Koninklijke DSM as its price is falling. RDSMY shares are trading up $1.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Koninklijke DSM? A short squeeze for Koninklijke DSM occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDSMY, which in turn drives the price of the stock up even further. How often is Koninklijke DSM's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDSMY, twice per month. The most recent reporting period available is October, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Asahi Kasei Short Interest Data FMC Short Interest Data Olin Short Interest Data Basf Short Interest Data Teck Resources Short Interest Data Wheaton Precious Metals Short Interest Data Franco-Nevada Short Interest Data Steel Dynamics Short Interest Data Novozymes A/S Short Interest Data Nutrien Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:RDSMY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlace